EGFR and neoplasm: These observations raise the possibility that mutations in the FGFR2 could contribute to tumour growth and metastasis formation in EC by regulating ADAM17‐mediated EGFR/ERK signalling pathways that induce proliferation and transformation in epithelial cells of the endometrium.